We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current JAZZ market cap is 6.88B. The company's latest EPS is USD 6.6538 and P/E is 16.52.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 940.65M | 972.12M | 892.81M | 957.32M | 972.14M |
| Operating Income | 158.41M | -263.39M | 126.06M | 157.64M | 172.39M |
| Net Income | -19.65M | -240.72M | 69.42M | 104.44M | 146.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.16B | 2.36B | 3.09B | 3.66B | 3.83B |
| Operating Income | 532.37M | 378.07M | 170.28M | 68.12M | 578.58M |
| Net Income | 523.37M | 238.62M | -329.67M | -224.06M | 414.83M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.38B | 10.84B | 11.05B | 11.26B | 11.2B |
| Total Liabilities | 7.64B | 7.75B | 7.71B | 7.73B | 7.71B |
| Total Equity | 2.75B | 3.09B | 3.34B | 3.53B | 3.49B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.54B | 6.54B | 12.3B | 10.84B | 11.39B |
| Total Liabilities | 2.43B | 2.88B | 8.33B | 7.75B | 7.66B |
| Total Equity | 3.11B | 3.66B | 3.97B | 3.09B | 3.74B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 930.01M | 1.27B | 320.71M | 617.47M | 924.67M |
| Investing | -121.85M | -446.23M | -4.82M | -90.56M | -264.86M |
| Financing | -549.09M | -529.49M | -29.79M | -126.46M | -204.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 776.4M | 899.65M | 778.51M | 1.27B | 1.09B |
| Investing | -155.3M | -1.01B | -5.21B | -446.23M | -163.06M |
| Financing | -293.75M | 528.07M | 3.97B | -529.49M | -305.25M |
| Market Cap | 6.88B |
| Price to Earnings Ratio | 16.52 |
| Price to Sales Ratio | 1.79 |
| Price to Cash Ratio | 4.55 |
| Price to Book Ratio | 1.83 |
| Dividend Yield | - |
| Shares Outstanding | 62.35M |
| Average Volume (1 week) | 547.42k |
| Average Volume (1 Month) | 604.03k |
| 52 Week Change | -22.79% |
| 52 Week High | 146.70 |
| 52 Week Low | 106.605 |
| Spread (Intraday) | 3.16 (2.82%) |
| Company Name | Jazz Pharmaceuticals PLC |
| Address |
15th floor, waterloo exchange dublin D04 E5W7 |
| Website | https://www.jazzpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
